Related Experiment Video
Updated: Sep 10, 2025

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Radionuclide imaging techniques for assessing myocardial viability: Clinical applications, evidence, and future
Jonathan D Knott1, Ellen Kronzer1, Nandan Anavekar1
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Insights
Radionuclide imaging, including SPECT and PET, assesses myocardial viability in ischemic cardiomyopathy. While PET offers superior accuracy, SPECT remains accessible, guiding treatment decisions for heart failure patients.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Ischemic cardiomyopathy (ICM) is a primary cause of heart failure worldwide.
- Myocardial viability testing identifies potentially reversible heart muscle dysfunction in ICM patients.
- Radionuclide imaging plays a crucial role in assessing myocardial viability.
Purpose of the Study:
- To review the clinical application and diagnostic performance of radionuclide imaging techniques for myocardial viability assessment in ICM.
- To compare the utility of thallium-201 (201Tl) SPECT, technetium-99m (99mTc) SPECT, and fluorine-18-fluorodeoxyglucose (18F-FDG) PET.
Main Methods:
- Review of clinical applications and diagnostic performance of 201Tl SPECT, 99mTc SPECT, and 18F-FDG PET.
- Evaluation of imaging characteristics, protocols, and results for each modality.
- Analysis of study outcomes associating viability with revascularization benefits.
Main Results:
- 201Tl SPECT uses uptake and redistribution but has limitations in protocol length and image quality.
- 99mTc SPECT offers improved resolution and faster imaging, enhanced with nitrate or gating.
- 18F-FDG PET is the gold standard due to superior sensitivity, image quality, and quantitative myocardial blood flow assessment.
Conclusions:
- Radionuclide imaging is valuable for assessing myocardial viability in ICM.
- PET provides superior diagnostic accuracy, while SPECT remains widely accessible.
- Further research with advanced imaging and therapies is needed to refine viability testing's role in revascularization strategies.
Abstract:
Ischemic cardiomyopathy (ICM) is a leading cause of heart failure globally. Myocardial viability testing aims to identify dysfunctional but potentially reversible myocardium in patients with ICM. This review examines the clinical application and diagnostic performance of radionuclide imaging techniques including thallium-201 (201Tl) and technetium-99 m (99mTc) single positron emission tomography (SPECT), and flourine-18-flourodeoxyglucose (18F-FDG) positron emission tomography (PET) for assessing myocardial viability. 201TI SPECT assesses viability via active myocardial uptake and delayed redistribution but is limited by prolonged protocols and suboptimal image quality. 99mTc-labeled agents (sestamibi and tetrofosmin) offer improved spatial resolution, shorter half-life, and higher photon energy, enabling faster imaging and better image quality. When combined with nitrate augmentation or gated imaging, 99mTc SPECT enhances detection of viable but under perfused myocardium. 18F-FDG PET is considered the gold standard modality for viability assessment due to its superior sensitivity, image quality and quantitative capabilities for myocardial blood flow. While observational studies associate viability with improved outcomes after revascularization, randomized trials have yielded mixed results. However, contemporary guidelines continue to support viability testing in selected high-risk patients. Emerging technologies including novel PET tracers, artificial intelligence, and hybrid imaging may further improve diagnostic accuracy and clinical utility of radionuclide viability testing. Radionuclide imaging remains a valuable tool in assessing myocardial viability in ICM. While PET offers superior diagnostic accuracy, SPECT remains widely used given its accessibility. Future studies incorporating modern imaging technologies and contemporary heart failure therapies are needed to clarify the role of viability testing in guiding revascularization strategies.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Acute Coronary Syndrome III: Diagnostic Studies

